About LDR (NASDAQ:LDRH)
LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company's primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company's VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company's Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company's traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E Ratio-52.0845070422535
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-16.37%
Return on Assets-13.65%
LDR (NASDAQ:LDRH) Frequently Asked Questions
What is LDR's stock symbol?
LDR trades on the NASDAQ under the ticker symbol "LDRH."
How were LDR's earnings last quarter?
LDR Holding Corp (NASDAQ:LDRH) issued its quarterly earnings data on Tuesday, May, 10th. The medical device company reported ($0.26) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.24) by $0.02. The medical device company had revenue of $42.40 million for the quarter, compared to analyst estimates of $42.90 million. LDR had a negative net margin of 18.02% and a negative return on equity of 16.37%. The firm's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.12) EPS. View LDR's Earnings History.
Who are some of LDR's key competitors?
Some companies that are related to LDR include Covidien (COV), Baxter International (BAX), C R Bard (BCR), Zimmer Biomet (ZBH), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), CareFusion (CFN), Steris (STE), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), Hill-Rom (HRC), DexCom (DXCM), Globus Medical (GMED), ICU Medical (ICUI), VWR (VWR), Integra Lifesciences (IART), LivaNova (LIVN) and Haemonetics (HAE).
How do I buy LDR stock?
Shares of LDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is LDR's stock price today?
One share of LDR stock can currently be purchased for approximately $36.98.
How can I contact LDR?
LDR's mailing address is 13785 N Highway 183 Ste 200, AUSTIN, TX 78750-1895, United States. The medical device company can be reached via phone at +1-512-3443333.
MarketBeat Community Rating for LDR (LDRH)MarketBeat's community ratings are surveys of what our community members think about LDR and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
LDR (NASDAQ:LDRH) Earnings History and Estimates Chart
LDR (NASDAQ LDRH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/10/2016||Q1||($0.24)||($0.26)||$42.90 million||$42.40 million||View||Listen|
|2/17/2016||Q4||($0.17)||($0.16)||$42.37 million||$44.50 million||View||Listen|
|11/4/2015||Q3||($0.19)||($0.07)||$39.25 million||$39.29 million||View||N/A|
|8/5/2015||Q215||($0.18)||($0.22)||$39.17 million||$41.50 million||View||N/A|
|5/6/2015||Q414||($0.20)||($0.12)||$36.20 million||$39.10 million||View||N/A|
|2/18/2015||Q4||($0.16)||($0.12)||$36.40 million||$39.50 million||View||N/A|
|11/5/2014||Q314||($0.21)||($0.08)||$32.40 million||$35.90 million||View||N/A|
|8/6/2014||Q214||($0.14)||($0.09)||$31.14 million||$34.80 million||View||N/A|
|5/7/2014||Q114||($0.17)||($0.15)||$30.13 million||$31.07 million||View||N/A|
|2/27/2014||Q413||($0.29)||($0.69)||$28.02 million||$32.00 million||View||N/A|
|11/6/2013||Q3 2013||($0.27)||($0.29)||$24.77 million||$27.20 million||View||N/A|
LDR (NASDAQ:LDRH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for LDR (NASDAQ:LDRH)
No dividend announcements for this company have been tracked by MarketBeat.com
LDR (NASDAQ LDRH) Insider Trading and Institutional Ownership History
LDR (NASDAQ LDRH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|4/15/2016||Patrick Richard||EVP||Sell||25,000||$27.60||$690,000.00||528,463|| |
|4/12/2016||Patrick Richard||EVP||Sell||25,000||$26.50||$662,500.00||578,063|| |
|3/11/2016||G. Joseph Ross||VP||Sell||17,613||$23.07||$406,331.91||7,520|| |
|7/10/2015||Christophe Lavigne||CEO||Sell||20,000||$40.07||$801,400.00|| |
|6/10/2015||Christophe Lavigne||CEO||Sell||20,000||$44.55||$891,000.00|| |
|5/19/2015||Stefan K Widensohler||Director||Sell||100,000||$40.17||$4,017,000.00|| |
|5/15/2015||James Burrows||COO||Sell||1,263||$39.00||$49,257.00|| |
|5/14/2015||Christophe Lavigne||CEO||Sell||50,000||$38.68||$1,934,000.00|| |
|5/11/2015||Robert Mcnamara||CFO||Sell||17,045||$38.13||$649,925.85|| |
|4/10/2015||Christophe Lavigne||CEO||Sell||20,000||$38.19||$763,800.00|| |
|3/13/2015||Robert Mcnamara||CFO||Sell||8,300||$38.03||$315,649.00|| |
|3/12/2015||Stefan K Widensohler||Director||Sell||50,000||$37.83||$1,891,500.00|| |
|3/10/2015||Christophe Lavigne||CEO||Sell||31,600||$37.65||$1,189,740.00|| |
|3/10/2015||Stefan K Widensohler||Director||Sell||50,000||$37.73||$1,886,500.00|| |
|3/6/2015||Christophe Lavigne||CEO||Sell||38,400||$37.84||$1,453,056.00|| |
|3/6/2015||Stefan K Widensohler||Director||Sell||43,423||$37.95||$1,647,902.85|| |
|3/5/2015||G. Joseph Ross||VP||Sell||31,376||$37.91||$1,189,464.16|| |
|3/4/2015||Stefan K Widensohler||Director||Sell||73,500||$38.09||$2,799,615.00|| |
|3/3/2015||Robert Mcnamara||CFO||Sell||3,785||$38.02||$143,905.70|| |
|3/3/2015||Stefan K Widensohler||Director||Sell||25,000||$37.90||$947,500.00|| |
|3/2/2015||Robert Mcnamara||CFO||Sell||1,304||$39.01||$50,869.04|| |
|3/2/2015||Stefan K Widensohler||Director||Sell||25,000||$38.51||$962,750.00|| |
|2/23/2015||Robert G Shepler||Major Shareholder||Sell||222,767||$38.00||$8,465,146.00|| |
|2/17/2015||Christophe Lavigne||CEO||Sell||25,000||$37.24||$931,000.00|| |
|1/15/2015||Christophe Lavigne||CEO||Sell||25,000||$33.46||$836,500.00|| |
|12/15/2014||Christophe Lavigne||CEO||Sell||25,000||$31.64||$791,000.00|| |
|12/11/2014||Robert Mcnamara||CFO||Sell||5,555||$32.00||$177,760.00|| |
|11/17/2014||Christophe Lavigne||CEO||Sell||25,000||$34.03||$850,750.00|| |
|10/1/2014||Telegraph Hill Partners Ii L P||Major Shareholder||Sell||28,075||$31.49||$884,081.75|| |
|9/30/2014||Robert G Shepler||Major Shareholder||Sell||6,527||$31.35||$204,621.45|| |
|9/29/2014||Robert G Shepler||Major Shareholder||Sell||21,348||$31.54||$673,315.92|| |
|9/26/2014||Telegraph Hill Partners Ii L P||Major Shareholder||Sell||200,000||$31.22||$6,244,000.00|| |
|9/25/2014||Telegraph Hill Partners Ii L P||Major Shareholder||Sell||75,000||$31.03||$2,327,250.00|| |
|9/24/2014||Telegraph Hill Partners Ii L P||Major Shareholder||Sell||25,000||$31.14||$778,500.00|| |
|9/18/2014||Scott E Way||VP||Sell||3,333||$30.00||$99,990.00|| |
|9/17/2014||Christophe Lavigne||CEO||Sell||25,000||$28.02||$700,500.00|| |
|8/26/2014||Christophe Lavigne||CEO||Sell||25,000||$28.00||$700,000.00|| |
|8/15/2014||James Burrows||COO||Sell||19,258||$26.59||$512,070.22|| |
|8/15/2014||Robert Mcnamara||CFO||Sell||20,000||$27.19||$543,800.00|| |
|8/15/2014||Scott E Way||VP||Sell||12,000||$26.76||$321,120.00|| |
|8/14/2014||James Burrows||COO||Sell||3,539||$26.00||$92,014.00|| |
|8/13/2014||James Burrows||COO||Sell||22,620||$24.78||$560,523.60|| |
|6/16/2014||Robert Mcnamara||CFO||Sell||40,000||$24.65||$986,000.00|| |
|6/11/2014||Christophe Lavigne||CEO||Sell||36,600||$24.50||$896,700.00|| |
|6/11/2014||Herve Dinville||EVP||Sell||22,650||$24.50||$554,925.00|| |
|6/11/2014||Stefan K Widensohler||Director||Sell||16,950||$24.50||$415,275.00|| |
|6/2/2014||Denise Cruz||Insider||Sell||1,111||$24.10||$26,775.10|| |
|6/2/2014||G. Joseph Ross||VP||Sell||3,137||$24.11||$75,633.07|| |
|5/20/2014||Christophe Lavigne||CEO||Sell||244,000||$24.50||$5,978,000.00||1,045,427|| |
|5/20/2014||Joseph Aragona||Director||Sell||570,000||$24.50||$13,965,000.00|| |
|5/20/2014||Keensight Capital||major shareholder||Sell||732,000||$24.50||$17,934,000.00|| |
|5/20/2014||Patrick Richard||EVP||Sell||151,000||$24.50||$3,699,500.00||429,668|| |
|10/15/2013||Robert G Shepler||Major Shareholder||Buy||50,000||$15.00||$750,000.00|| |
LDR (NASDAQ LDRH) News Headlines
LDR (NASDAQ:LDRH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
LDR (NASDAQ:LDRH) Income Statement, Balance Sheet and Cash Flow Statement
LDR (NASDAQ LDRH) Stock Chart for Sunday, February, 25, 2018